HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael A Ihnat Selected Research

Intravesical Administration

3/2007Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation.
3/2007Regulatory network of inflammation downstream of proteinase-activated receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael A Ihnat Research Topics

Disease

25Neoplasms (Cancer)
01/2021 - 05/2002
9Neoplasm Metastasis (Metastasis)
05/2015 - 12/2003
6Breast Neoplasms (Breast Cancer)
01/2021 - 05/2002
3Melanoma (Melanoma, Malignant)
05/2010 - 12/2003
3Hypoxia (Hypoxemia)
09/2009 - 08/2005
3Inflammation (Inflammations)
08/2007 - 03/2007
2Neoplasm Micrometastasis
01/2014 - 01/2013
2Diabetes Complications
02/2009 - 05/2008
2Edema (Dropsy)
03/2007 - 03/2007
2Carcinogenesis
08/2005 - 12/2003
1Hyperalgesia
01/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021
1Pain (Aches)
01/2021
1Disease Progression
01/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2018
1Glioma (Gliomas)
09/2017
1Necrosis
05/2015
1Colonic Neoplasms (Colon Cancer)
01/2014
1Fibrosarcoma
09/2013
1Type 2 Diabetes Mellitus (MODY)
02/2009
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2008
1Mitochondrial Diseases (Mitochondrial Disease)
06/2008
1Cystitis
03/2007

Drug/Important Bio-Agent (IBA)

3TubulinIBA
01/2021 - 05/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 03/2010
2Thalidomide (Thalomid)FDA Link
01/2021 - 05/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2017 - 08/2005
2Cytostatic AgentsIBA
01/2017 - 05/2014
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2017 - 05/2014
2Angiogenesis InhibitorsIBA
01/2017 - 05/2014
2Proteins (Proteins, Gene)FDA Link
05/2015 - 01/2014
2CD13 Antigens (Alanine Aminopeptidase)IBA
09/2013 - 01/2012
2probestinIBA
09/2013 - 06/2013
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2013 - 05/2010
2matrigelIBA
01/2013 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
03/2010 - 09/2009
2Glucose (Dextrose)FDA LinkGeneric
02/2009 - 05/2008
2Transcription Factors (Transcription Factor)IBA
08/2007 - 01/2007
2Proteinase-Activated ReceptorsIBA
08/2007 - 03/2007
2Peptides (Polypeptides)IBA
03/2007 - 03/2007
2Arsenic Trioxide (Trisenox)FDA Link
08/2005 - 12/2003
2ArsenicIBA
08/2005 - 12/2003
1Analgesics (Analgesic Drugs)IBA
01/2021
1Taxoids (Taxanes)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2018
1AndrogensIBA
01/2018
1Aminobutyrates (Aminobutyric Acid)IBA
01/2018
1Immunoglobulin G (IgG)IBA
09/2017
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2017
1Pemetrexed (MTA)FDA Link
01/2017
1SaltsIBA
01/2017
1Adenosine Triphosphate (ATP)IBA
05/2015
1DiaminesIBA
05/2015
1indoleIBA
05/2015
1HMGB1 Protein (HMG1)IBA
05/2015
1combretastatinIBA
05/2014
1Sunitinib (Sutent)FDA Link
05/2014
1CateninsIBA
01/2014
1ChromatinIBA
01/2014
1Oncogene Proteins (Oncogene Protein)IBA
01/2014
1DiarylheptanoidsIBA
01/2014
1Histone DemethylasesIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
09/2013
1Chelating AgentsIBA
09/2013
1AcidsIBA
09/2013
1stable plasma protein solutionIBA
06/2013
1Biological ProductsIBA
03/2013
1CollagenIBA
01/2013
1Collagen Type I (Type I Collagen)IBA
01/2013
1orantinib (SU6668)IBA
04/2012
1EnzymesIBA
01/2012
1FLLL 32IBA
03/2010
1AgarIBA
03/2010
1FLLL 31IBA
03/2010
1Pharmaceutical PreparationsIBA
03/2010
1Interleukin-6 (Interleukin 6)IBA
03/2010
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2010
1AntioxidantsIBA
09/2009
1ElementsIBA
09/2009
1NF-kappa B (NF-kB)IBA
09/2009
1Superoxide DismutaseIBA
09/2009
1PPAR gammaIBA
09/2009
1PPAR alphaIBA
09/2009
1Superoxide Dismutase-1IBA
09/2009
1Docosahexaenoic AcidsIBA
09/2009
1oxidized low density lipoproteinIBA
06/2008
1Retinaldehyde (Retinal)IBA
06/2008
1low density lipoprotein inhibitorIBA
06/2008
1ApolipoproteinsIBA
06/2008
1CaspasesIBA
06/2008
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2008
1Phosphotransferases (Kinase)IBA
05/2008
1tyrosine receptor (receptor, tyrosine)IBA
05/2008
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
08/2007

Therapy/Procedure

7Therapeutics
09/2017 - 12/2003
4Drug Therapy (Chemotherapy)
01/2017 - 05/2014
2Intravesical Administration
03/2007 - 03/2007
1Castration
01/2018